GSK buyout and institutional incentives

Carney details Sinclair's company sale to GlaxoSmithKline and how institutional interests amplified the claims.

Play episode from 03:07:11

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!